Esophageal Squamous Cell Carcinoma

Displaying 1 - 9 of 9CSV
Dunbar, K. J., Wong, K. K., & Rustgi, A. K. (2024). Cancer-Associated Fibroblasts in Esophageal Cancer. Cellular and Molecular Gastroenterology and Hepatology, 17(5), 687–695. https://doi.org/10.1016/j.jcmgh.2024.01.008
Publication Date
Flashner, S., Shimonosono, M., Tomita, Y., Matsuura, N., Ohashi, S., Muto, M., Klein-Szanto, A. J., Alan Diehl, J., Chen, C.-H., Mochly-Rosen, D., Weinberg, K. I., & Nakagawa, H. (2023). ALDH2 dysfunction and alcohol cooperate in cancer stem cell enrichment. Carcinogenesis, 45(1–2), 95–106. https://doi.org/10.1093/carcin/bgad085
Publication Date
Efe, G., Dunbar, K. J., Sugiura, K., Cunningham, K., Carcamo, S., Karaiskos, S., Tang, Q., Cruz-Acuña, R., Resnick-Silverman, L., Peura, J., Lu, C., Hasson, D., Klein-Szanto, A. J., Taylor, A. M., Manfredi, J. J., Prives, C., & Rustgi, A. K. (2023). p53 Gain-of-Function Mutation Induces Metastasis via BRD4-Dependent CSF-1 Expression. Cancer Discovery, 13(12), 2632–2651. https://doi.org/10.1158/2159-8290.cd-23-0601
Publication Date
Muthupalani, S., Annamalai, D., Feng, Y., Ganesan, S. M., Ge, Z., Whary, M. T., Nakagawa, H., Rustgi, A. K., Wang, T. C., & Fox, J. G. (2023). IL-1β transgenic mouse model of inflammation driven esophageal and oral squamous cell carcinoma. Scientific Reports, 13(1). https://doi.org/10.1038/s41598-023-39907-8
Publication Date
Ko, K.-P., Huang, Y., Zhang, S., Zou, G., Kim, B., Zhang, J., Jun, S., Martin, C., Dunbar, K. J., Efe, G., Rustgi, A. K., Nakagawa, H., & Park, J.-I. (2023). Key Genetic Determinants Driving Esophageal Squamous Cell Carcinoma Initiation and Immune Evasion. Gastroenterology, 165(3), 613-628.e20. https://doi.org/10.1053/j.gastro.2023.05.030
Publication Date
Dunbar, K. J., Karakasheva, T. A., Tang, Q., Efe, G., Lin, E. W., Harris, M., Sahu, V., Sachdeva, U. M., Hu, J., Klein-Szanto, A. J., Henick, B., Diehl, J. A., Nakagawa, H., & Rustgi, A. K. (2023). Tumor-Derived CCL5 Recruits Cancer-Associated Fibroblasts and Promotes Tumor Cell Proliferation in Esophageal Squamous Cell Carcinoma. Molecular Cancer Research, 21(7), 741–752. https://doi.org/10.1158/1541-7786.mcr-22-0872
Publication Date
Soroush, A., Malekzadeh, R., Roshandel, G., Khoshnia, M., Poustchi, H., Kamangar, F., Brennan, P., Boffetta, P., Dawsey, S. M., Abnet, C. C., Abrams, J. A., & Etemadi, A. (2022). Sex and smoking differences in the association between gastroesophageal reflux and risk of esophageal squamous cell carcinoma in a high‐incidence area: Golestan Cohort Study. International Journal of Cancer, 152(6), 1137–1149. Portico. https://doi.org/10.1002/ijc.34313
Publication Date
Flashner, S., Martin, C., Matsuura, N., Shimonosono, M., Tomita, Y., Morimoto, M., Okolo, O., Yu, V. X., Parikh, A. S., Klein-Szanto, A. J. P., Yan, K., Gabre, J. T., Lu, C., Momen-Heravi, F., Rustgi, A. K., & Nakagawa, H. (2022). Modeling Oral-Esophageal Squamous Cell Carcinoma in 3D Organoids. Journal of Visualized Experiments, 190. https://doi.org/10.3791/64676
Publication Date
Wang, Z., Wang, J., Zhao, H., Zhao, T., Chen, Y., Jiang, M., Zhang, S., Wei, Y., Zhang, J., Zhou, Y., Shi, S., Fu, Z., Yang, Y., Zhang, Y., Yang, L., Que, J., & Liu, K. (2022). Targeting the SOX2/PARP1 complex to intervene in the growth of esophageal squamous cell carcinoma. Biomedicine & Pharmacotherapy, 153, 113309. https://doi.org/10.1016/j.biopha.2022.113309
Publication Date